Skip to content
10-Q

Quarterly Report

ARMO BIOSCIENCES, INC.

0001193125-18-164205

← back to feed
Filed
May 15, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · May 10, 2018 30.41M sh
Capex Q1 2018 · Mar 31, 2018 $137K
Cash And Equivalents Q1 2018 · Mar 31, 2018 $165.31M
Cash And Equivalents Q1 2018 · Dec 31, 2017 $49.48M
Stockholders Equity Q1 2018 · Mar 31, 2018 $156.86M
Stockholders Equity Q1 2018 · Dec 31, 2017 −$132.53M
Current Liabilities Q1 2018 · Mar 31, 2018 $15.89M
Current Liabilities Q1 2018 · Dec 31, 2017 $11.65M
Current Assets Q1 2018 · Mar 31, 2018 $171.94M
Current Assets Q1 2018 · Dec 31, 2017 $52.1M
Total Assets Q1 2018 · Mar 31, 2018 $175.07M
Total Assets Q1 2018 · Dec 31, 2017 $56.19M
Sga Expense Q1 2018 · Mar 31, 2018 $3.08M
Sga Expense Q1 2018 · Mar 31, 2017 $1.69M
Rd Expense Q1 2018 · Mar 31, 2018 $19.04M
Rd Expense Q1 2018 · Mar 31, 2017 $7.73M
Net Income Q1 2018 · Mar 31, 2018 −$21.72M
Net Income Q1 2018 · Mar 31, 2017 −$9.4M
Operating Income Q1 2018 · Mar 31, 2018 −$22.12M
Operating Income Q1 2018 · Mar 31, 2017 −$9.41M
Stock Repurchased Q1 2018 · Mar 31, 2017 $6K